Some of the most important methods for preventing bias in modern clinical trials have a peculiar history. Masked assessment with placebo control seems to have appeared first during tests led by Benjamin Franklin in 1784 to investigate unorthodox claims of healing by 'animal magnetism' or 'mesmerism'. People were blindfolded and told that they were or were not receiving magnetism, when the reverse was true, and were given sham treatments of 'mesmerised water'. 1 Similar methods were used to test claims of 'higher' mesmeric phenomena such as thoughtreading and precognition. 2 Two-hundred years later, the same methodology is still used to assess controversial claims in parapsychology, a subdiscipline of experimental psychology, that uses controlled laboratory techniques to examine claims of psychic abilities. Recent problems noted with the conduct of clinical trials suggest that although the two fields have diverged, parapsychology might now have something to offer in the design of orthodox medical research.
Problems with allocation concealment
In some clinical trials, patients have been allocated to interventions in such a way that clinicians could predict or control what the next eligible patient will receive, for example, by allocating patients in alternating order, or by drawing marbles out of a bag without appropriate precautions to prevent sampling until the favoured option is drawn. It is well established that treatment estimates are biased in such trials in comparison with trials in which allocations are concealed. 3 This is presumably because clinicians can assign their favoured treatment to particular patients by giving allocations out of sequence, or manipulating whether or when certain patients enter the trial, resulting in baseline risk factor imbalance. Trialists have attempted to deal with the problem by concealing allocations from clinicians until assignment. Although centralized randomization offers a relatively secure method of concealment, it still appears much more common for trialists to attempt to conceal allocations at the trial sites. 4 However, there are many anecdotes, such as those documented by Schulz, 5 of trial clinicians' attempts to breach such concealment. The methods described include holding envelopes containing allocations up to a light bulb, deciphering the allocation sequence by examining the appearance of the tablets in the sequentially numbered medication containers, and rifling through the principal investigator's filing cabinet.
As in clinical trials, parapsychologists testing claims of extrasensory perception must also conceal material from people who would like to know its contents; a typical parapsychology experiment consists of concealing a random sequence of symbols from a participant who attempts to guess it. Particularly when testing participants such as Uri Geller who make strong claims about their psychic abilities, experimenters must defend against cheating so that any positive results from the study can be taken seriously. 6 This is not a trivial problem in parapsychology. People have such strong opinions about psychic claims that some laboratories have been infiltrated by performance magicians posing as psychics to attempt to trick the experimenters and discredit their methods. 7 
Spies, magicians, and envelopes
The literature that parapsychologists draw upon to conceal adequately their materials is (sometimes deliberately) obscure and mostly unknown to clinical trialists, but it has much to say about methods commonly used for allocation concealment used in trials. Sealed, opaque envelopes are an interesting case in point. As any reader of junior detective novels will know, envelopes with water-soluble glue on the flaps can be steamed open. Military intelligence specialists have also long known this, as documented in the CIA Flaps and Seals Manual. 8 The Manual is essentially a 'spies handbook' of how to get into and out of other people's envelopes without their knowledge. In addition to the more pedestrian methods of tampering with flaps, it includes, for example, a section on how to use carbon tetrachloride, which is highly toxic, to open envelopes sealed with sellotape without detection and without killing yourself. There are also sections on how to set booby traps to detect whether someone has opened and resealed an envelope in transit, such as leaving a section of the flap unglued which the interceptor might seal completely after opening. Further sections describe methods for detecting booby traps, for example by examining an envelope under ultraviolet light to detect the use of more than one type of glue on the flap.
Parapsychology also draws on the expertise of the commercial security industry concerning concealment materials. Some companies manufacture special, 'tamper evident' security envelopes to protect against industrial espionage or blackmail concerning sensitive information in transit. Many such envelopes are made out of plastics that deform or stain if solvents are used to attack the glue on the flap. Some envelopes can be opened surreptiously by freezing, which makes the glue brittle and cracked, enabling the flap to be lifted easily and the contents of the envelope to be examined. The contents can be replaced in the envelope, and the flap placed back down. As the envelope returns to room temperature the glue melts and reseals the envelope. Many security envelopes are therefore made from materials that show evidence of having been subjected to extremes of temperature.
In order to protect against another weakness of ordinary envelopes-their transparency if placed in front of an intense light source, as noted by some of Schulz's 5 respondents-some commercial security envelopes are lined with black plastic. The use of plastic also protects against the use of special wetting agents, which can render transparent envelopes made out of quite thick paper. This technique has long been used by magicians to simulate psychic powers on stage. For example, a magician might ask a member of the audience to draw a picture on a sheet of paper without letting him or her see it, to seal the picture in an opaque envelope, and pass it to the magician, who then describes its contents without opening it. One of the many ways of doing this trick involves the magician unobtrusively applying a wetting agent to the envelope from a small vial through a tube to a flesh-coloured sponge attached to his or her finger. The surface becomes temporarily transparent, enabling the contents of the envelope to be read, and the wetting agent evaporates quickly, leaving little trace. 9 A company in the US has recently exploited this principle to develop a spray that allows law enforcement agencies to inspect covertly suspect packages that might contain bombs, without opening them. 10 Tamper-evident envelopes manufactured by specialist security firms are commercially available and could be used in clinical trials, though trialists should choose their materials carefully. Products change often, offer varying degrees of protection against interference and, even if described as being tamper evident, have not necessarily been subjected to testing. For example, some security envelopes appropriately use solvent-resistant glue on the flaps but use water-soluble glue on the seals. Trial investigators concerned about security can find a range of potentially useful and currently available materials by using search terms such as 'tamper evident' on the internet, but should obtain sample materials and conduct their own tests on them before making a choice.
Conclusions
Trial clinicians without special knowledge or training are unlikely to go to some of the more extreme and colourful lengths described here. However, several of the methods are either common knowledge or easily re-invented and do not require unusual equipment or materials. The general point to be taken from the expertise in these other fields is that if envelopes, and other on-site concealment methods, are used in trials they should incorporate appropriate security measures and be adequately tracked through the trial to prevent premature opening. Concealment methods should be described in much more detail than is usual in trial reports so that readers can assess their adequacy. Inexpensive centralized randomization is becoming more widely available and obviates many of these problems. While on-site concealment continues to be used, however, clinical researchers might do well to consider spies and magicians when designing their trials.
KEY MESSAGES
• Some important aspects of clinical trial methodology have their historical basis in investigations of paranormal phenomena.
• The methodology of such investigations has continued to develop, drawing upon little-known literatures in fields such as performance magic, and military and industrial espionage.
• Some material from these fields suggest ways in which randomized trials may be better protected against clinicians' attempts to breach allocation concealment.
